No, unfortunately. I used to have a Merrill account, and for some reason I stayed on this one mailing list. All other buttons that gave me access beyond the password gate are inactivated now.
Highlights of this issue The US 1 list is intended to represent a collection of our best investment ideas that are drawn from the universe of “Buy” rated US-listed stocks (including ADRs), covered by BofA Merrill Lynch fundamental equity research analysts. The list will be managed with a goal of providing superior investment performance over the long term. Allergan (AGN) is being removed from the US 1 list today due to the stock being placed under “extended review